Seeking Alpha
05 May 2026, 00:43 UTC · 20w ago
Mirum Pharmaceuticals, Inc. (MIRM) Discusses Topline Clinical Results in Primary Sclerosing Cholangitis and Hepatitis Delta Transcript
Verdict
Headline takes no side. We score MIRM +0.20 — slightly bullish.
- Expected · MIRM
+0.20slightly bullish
−1 bearish0bullish +1More positive than 57% of ticker scores this week



